Gladstone Institutional Advisory’s Anavex Life Sciences AVXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $459K | Buy |
49,765
+17,950
| +56% | +$165K | 0.02% | 517 |
|
|
2025
Q1 | $273K | Buy |
31,815
+5,800
| +22% | +$49.8K | 0.01% | 606 |
|
|
2024
Q4 | $279K | Buy |
+26,015
| New | +$279K | 0.01% | 605 |
|
|
2023
Q3 | – | Sell |
-18,000
| Closed | -$146K | – | 622 |
|
|
2023
Q2 | $146K | Sell |
18,000
-160
| -0.9% | -$1.3K | 0.01% | 603 |
|
|
2023
Q1 | $156K | Hold |
18,160
| – | – | 0.01% | 620 |
|
|
2022
Q4 | $168K | Buy |
+18,160
| New | +$168K | 0.01% | 611 |
|